Mitral valve

Is Edge-to-Edge Treatment with PASCAL Effective at 3 Years?

Mitral regurgitation is the most common valvular heart disease. Its cause is most frequently functional or secondary...

Cerebrovascular Events in the COAPT Study

Transcatheter edge-to-edge repair (TEER) with MitraClip has demonstrated its benefit compared with complete guideline-directed medical therapy (GDMT),...

COAPT: Nutritional Condition Is an Important Factor in Edge-to-Edge Treatment

Heart failure is strongly associated with malnutrition or poor nutrition, which has been linked to increased mortality...

Mitral Valve Surgery after Edge-to-Edge Repair

In last few years, transcatheter edge-to-edge repair (TEER) with MitraClip has been shown safe and effective, both...

Echo- Stress during Edge-to-Edge Mitral Valve Repair Can Be Useful

Transcatheter edge-to-edge mitral valve repair with Mitraclip has become a valid strategy to treat mitral valve regurgitation...

Latest Developments in Tricuspid Regurgitation

The natural history of tricuspid regurgitation is associated to hospitalization for cardiac failure and mortality. This is...

MitraScore: What Does the Final Result of Edge-to-Edge Treatment of Mitral Regurgitation Provide?

Edge-to-edge treatment has proven to be a safe and effective technique in follow-up, decreasing mortality and hospitalizations...

TriClip: Tricuspid Regurgitation Dedicated Device

Severe tricuspid regurgitation (TR) is difficult to manage and is associated to high morbimortality.  Surgical repair is complex...